Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints CEO

Jamie Macdonald succeeds co-founder Josef von Rickenbach

Jamie MacdonaldBiopharmaceutical services provider, Parexel, has appointed Jamie Macdonald as its chief executive officer (CEO), a role that will see him succeed Josef von Rickenbach.

Macdonald previously led INC Research, now known as Syneos Health, for several years first as CEO and most recently as vice chairman.

He has also served as senior vice president and head of global project management at Quintiles, now IQVIA.

Macdonald said: “As a trail blazer in the biopharmaceutical services industry, the company enjoys well-deserved recognition as having the kind of deep therapeutic and functional expertise, global reach and innovative capability to continue its leadership.

“I am humbled to have the opportunity to build on this legacy and look forward to continued growth and excellence for Parexel.”

20th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics